
zzso zzso an zzso zzso is a selective zzso zzso of normal zzso that provides zzso against zzso radiation and zzso agents, thus preserving the efficacy of zzso and zzso This review summarizes the zzso data and clinical experience with zzso and provides insight into future clinical zzso zzso an inactive zzso is transformed to an active zzso after zzso by alkaline zzso found in the normal zzso The absence of alkaline zzso in the zzso zzso and zzso zzso and the zzso and acidity of the tumor environment, may explain its zzso zzso The zzso mechanism of zzso is complicated, involving free radical zzso DNA protection and repair zzso and induction of cellular zzso zzso administration of zzso zzso zzso before chemotherapy and zzso zzso before each zzso fraction are widely used zzso The US Food and Drug Administration has approved the use of zzso as a zzso for zzso chemotherapy and for zzso zzso zzso trials are being conducted to determine the efficacy of zzso in reducing zzso zzso and other zzso Novel schedules and routes of administration are under investigation, and may further simplify the use of zzso and considerably broaden its zzso 

